Xavier Pivot

20.3k citations
379 papers · 12.3k · 4 hit papers · h-index 53

Impact in

  • Oncology top 0.1%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways
    • Colorectal Cancer Treatments and Studies
    • Breast Cancer Treatment Studies

Papers in

    • HER2/EGFR in Cancer Research 115
    • Cancer Treatment and Pharmacology 102
    • Colorectal Cancer Treatments and Studies 23
    • Global Cancer Incidence and Screening 17
    • Advanced Breast Cancer Therapies 53

Xavier Pivot

372 papers receiving 12.0k citations

Xavier Pivot's Hit Papers

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 2019 · 632 citations
6320+5+11Years since publication2505007501000

Peers

Xavier Pivot
Comparison fields: 5 of 133
  • Oncology 7.0k
  • Cancer Research 2.1k
  • Pulmonary and Respiratory Medicine 3.5k
  • Otorhinolaryngology 319
  • Genetics 563
Replace George R. Blumenschein with:
George R. Blumenschein United States
Christophe Massard France
Kathy S. Albain United States
Edward S. Kim United States
Howard S. Höchster United States
Sabino De Placido Italy
Patrick Schöffski Belgium
Afshin Dowlati United States
Daniel D. Karp United States
Jin Seok Ahn South Korea
Xavier Pivot relative to George R. Blumenschein United States George R. Blumenschein's profile →
Citations per field
00.5×1.5×1.8×
George R. Blumenschein · 1×
Citations per year

Countries citing papers authored by Xavier Pivot

Since Specialization
Citations

This map shows the geographic impact of Xavier Pivot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Pivot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Pivot more than expected).

Fields of papers citing papers by Xavier Pivot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Pivot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Pivot. The network helps show where Xavier Pivot may publish in the future.

Co-authors

The 25 scholars most cited alongside Xavier Pivot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xavier Pivot Line = papers co-authored together Xavier Pivot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 379 papers — load more, or switch the sort, to bring in the rest.

#Work
1
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
Hit paper breakdown →
20171161
2
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
Hit paper breakdown →
2009806
3
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
Hit paper breakdown →
2010728
4
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
Hit paper breakdown →
2019632
5 2007399
6 2007318
7 2017305
8 2004265
9 2013216
10 2012188
11 2013180
12 2010170
13 2008169
14 2003159
15 2008153
16 2007125
17 2013123
18 2010121
19 2003116
20 1998113

About Xavier Pivot

Xavier Pivot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 379 papers that have together received 12.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (115 papers), Cancer Treatment and Pharmacology (102 papers), Breast Cancer Treatment Studies (63 papers), Advanced Breast Cancer Therapies (53 papers), Monoclonal and Polyclonal Antibodies Research (31 papers), Colorectal Cancer Treatments and Studies (23 papers), Head and Neck Cancer Studies (18 papers) and Global Cancer Incidence and Screening (17 papers). The work is most often cited by research in Oncology (7.0k citations), Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (3.5k citations), Otorhinolaryngology (319 citations) and Genetics (563 citations). Xavier Pivot has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Gilles Romieu, Joohyuk Sohn, Antonio Llombart‐Cussac, Masakazu Toi, Arlene Chan, Javier Cortés, Patrick Neven, Norikazu Masuda, Eva‐Maria Grischke and George W. Sledge. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, European Journal of Cancer and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact